/**
 * Research Agent
 * Searches medical literature and databases for evidence-based information
 */

import { BaseAgent, AgentConfig } from "./base-agent"

export class ResearchAgent extends BaseAgent {
  constructor() {
    const config: AgentConfig = {
      name: "Research Agent",
      role: "Medical Literature Researcher",
      systemPrompt: `You are a medical research specialist AI agent. Your role is to:
- Search medical databases and literature for evidence-based information
- Provide summaries of clinical guidelines and research findings
- Cite sources and explain medical concepts clearly
- Focus on recent, peer-reviewed evidence
- Always consider clinical context and patient safety

When asked about medical conditions, medications, or treatments:
1. Search relevant databases using available MCP tools
2. Synthesize information from multiple sources
3. Provide evidence-based recommendations
4. Note any contraindications or warnings
5. Use clear, professional medical terminology

You have access to medical databases through MCP tools.`,
    }
    super(config)
  }

  async process(input: string, context?: any): Promise<string> {
    this.addToHistory({ role: "user", content: input })

    // In a real implementation, this would call Claude API with MCP tools
    // For demo purposes, we'll simulate the research process

    const response = await this.simulateResearch(input, context)

    this.addToHistory({ role: "assistant", content: response })
    return response
  }

  private async simulateResearch(query: string, context?: any): Promise<string> {
    // Simulate MCP tool calls and research
    const lowerQuery = query.toLowerCase()

    if (lowerQuery.includes("diabetes") || lowerQuery.includes("t2d")) {
      return `**Research Findings: Type 2 Diabetes**

Based on current clinical guidelines (ADA 2024):

**Pathophysiology:**
- Progressive insulin resistance and beta-cell dysfunction
- Often associated with obesity, sedentary lifestyle

**Evidence-Based Management:**
1. **First-line:** Metformin (unless contraindicated)
   - Reduces HbA1c by 1-2%
   - Cardiovascular benefits demonstrated in UKPDS

2. **Lifestyle Modifications:**
   - 5-10% weight loss can significantly improve glycemic control
   - 150 minutes moderate exercise weekly

**Glycemic Targets:**
- HbA1c < 7% for most adults
- Individualize based on: age, comorbidities, hypoglycemia risk

**Monitoring:**
- HbA1c every 3-6 months
- Annual: nephropathy screening, retinal exam, foot exam

**Source:** ADA Standards of Care 2024, UKPDS Study`
    }

    if (lowerQuery.includes("hypertension") || lowerQuery.includes("blood pressure")) {
      return `**Research Findings: Hypertension Management**

Based on ACC/AHA Guidelines 2024:

**Classification:**
- Normal: < 120/80 mmHg
- Elevated: 120-129/<80 mmHg
- Stage 1: 130-139/80-89 mmHg
- Stage 2: ≥ 140/90 mmHg

**Treatment Approach:**
1. **Lifestyle First:** DASH diet, sodium restriction, exercise, weight loss
2. **Pharmacotherapy** (if BP ≥ 130/80 with CVD risk or ≥ 140/90):
   - First-line: ACE-I, ARB, CCB, or thiazide diuretic
   - Consider combination therapy for Stage 2

**Target BP:** < 130/80 mmHg for most patients

**SPRINT Trial:** Intensive control (< 120 systolic) reduced CVD events by 25% in high-risk patients

**Source:** ACC/AHA Hypertension Guidelines, SPRINT Trial`
    }

    return `**Research Analysis**

I've analyzed your query: "${query}"

For accurate, evidence-based medical information, I recommend:
1. Consulting current clinical practice guidelines
2. Reviewing recent systematic reviews and meta-analyses
3. Considering individual patient factors

Please provide more specific details about the condition, medication, or clinical scenario you'd like me to research, and I'll provide comprehensive, evidence-based information.`
  }
}
